Abstract: This study addresses the challenge of precise control of the maglev system under the condition of rapid time-varying dynamics and large time delay. Maglev technology has been applied in many ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

While the creation of this new entity marks a big step toward avoiding a U.S. ban, as well as easing trade and tech-related tensions between Washington and Beijing, there is still uncertainty ...

As the world races to build artificial superintelligence, one maverick bioengineer is testing how much unprogrammed intelligence may already be lurking in our simplest algorithms to determine whether ...

The original version of this story appeared in Quanta Magazine. If you want to solve a tricky problem, it often helps to get organized. You might, for example, break the problem into pieces and tackle ...

The original version of this story appeared in Quanta Magazine. One July afternoon in 2024, Ryan Williams set out to prove himself wrong. Two months had passed since he’d hit upon a startling ...

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline. Shrinking the Salt Lake City-based company’s ...

While Artificial Intelligence (AI) has emerged as groundbreaking and significantly impacting various sectors and enhancing quality of life, the chasm between technological advancements and the law is ...

One July afternoon in 2024, Ryan Williams set out to prove himself wrong. Two months had passed since he’d hit upon a startling discovery about the relationship between time and memory in computing.

Researchers have found that wild orangutans vocalize with a layered complexity previously thought to be unique to human communication, suggesting a much older evolutionary origin. In groundbreaking ...

Pipeline: Delivered on our commitment to a more focused R&D strategy by advancing a streamlined portfolio of 5+ clinical and preclinical programs in oncology and rare disease, while deprioritizing 3 ...